In breast cancer patients, the ABCB5 SNP rs3210441 was associated with response to neoadjuvant cytotoxic therapy and ABCB5 expression in TCGA was associated with anthracycline resistance[62,96]. Here, ABCB5 is linked to breast carcinoma.